325 related articles for article (PubMed ID: 23662191)
1. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
Archer SL; Fang YH; Ryan JJ; Piao L
Pulm Circ; 2013 Jan; 3(1):144-52. PubMed ID: 23662191
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
[TBL] [Abstract][Full Text] [Related]
3. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
[TBL] [Abstract][Full Text] [Related]
5. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
Ryan JJ; Archer SL
Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
[TBL] [Abstract][Full Text] [Related]
6. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
Piao L; Marsboom G; Archer SL
J Mol Med (Berl); 2010 Oct; 88(10):1011-20. PubMed ID: 20820751
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dynamics in pulmonary arterial hypertension.
Ryan J; Dasgupta A; Huston J; Chen KH; Archer SL
J Mol Med (Berl); 2015 Mar; 93(3):229-42. PubMed ID: 25672499
[TBL] [Abstract][Full Text] [Related]
10. Bawei Chenxiang Wan ameliorates right ventricular hypertrophy in rats with high altitude heart disease by SIRT3-HIF1α-PDK/PDH signaling pathway improving fatty acid and glucose metabolism.
Han Y; Li S; Zhang Z; Ning X; Wu J; Zhang X
BMC Complement Med Ther; 2024 May; 24(1):190. PubMed ID: 38750550
[TBL] [Abstract][Full Text] [Related]
11. Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.
Spyropoulos F; Michael Z; Finander B; Vitali S; Kosmas K; Zymaris P; Kalish BT; Kourembanas S; Christou H
Front Cardiovasc Med; 2021; 8():662870. PubMed ID: 34222363
[No Abstract] [Full Text] [Related]
12. Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.
Wu D; Dasgupta A; Read AD; Bentley RET; Motamed M; Chen KH; Al-Qazazi R; Mewburn JD; Dunham-Snary KJ; Alizadeh E; Tian L; Archer SL
Free Radic Biol Med; 2021 Jul; 170():150-178. PubMed ID: 33450375
[TBL] [Abstract][Full Text] [Related]
13. Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications.
Archer SL
Adv Exp Med Biol; 2016; 903():29-53. PubMed ID: 27343087
[TBL] [Abstract][Full Text] [Related]
14. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.
Sutendra G; Dromparis P; Paulin R; Zervopoulos S; Haromy A; Nagendran J; Michelakis ED
J Mol Med (Berl); 2013 Nov; 91(11):1315-27. PubMed ID: 23846254
[TBL] [Abstract][Full Text] [Related]
15. Supra-coronary aortic banding improves right ventricular function in experimental pulmonary arterial hypertension in rats by increasing systolic right coronary artery perfusion.
Tian L; Xiong PY; Alizadeh E; Lima PDA; Potus F; Mewburn J; Martin A; Chen KH; Archer SL
Acta Physiol (Oxf); 2020 Aug; 229(4):e13483. PubMed ID: 32339403
[TBL] [Abstract][Full Text] [Related]
16. Right ventricular adaptation and failure in pulmonary arterial hypertension.
Ryan JJ; Huston J; Kutty S; Hatton ND; Bowman L; Tian L; Herr JE; Johri AM; Archer SL
Can J Cardiol; 2015 Apr; 31(4):391-406. PubMed ID: 25840092
[TBL] [Abstract][Full Text] [Related]
17. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Morales-Cano D; Izquierdo-García JL; Barreira B; Esquivel-Ruiz S; Callejo M; Pandolfi R; Villa-Valverde P; Rodríguez I; Cogolludo A; Ruiz-Cabello J; Perez-Vizcaino F; Moreno L
Front Pharmacol; 2023; 14():1021535. PubMed ID: 37063275
[No Abstract] [Full Text] [Related]
18. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
19. FDG PET imaging for identifying pulmonary hypertension and right heart failure.
Ahmadi A; Ohira H; Mielniczuk LM
Curr Cardiol Rep; 2015 Jan; 17(1):555. PubMed ID: 25504422
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Anaplerosis Attenuated Vascular Proliferation in Pulmonary Arterial Hypertension.
Valuparampil Varghese M; James J; Eccles CA; Niihori M; Rafikova O; Rafikov R
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32041182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
